Nemours receives grant to examine behavioral health intervention for adolescents with Type 1 diabetes

Susana R. Patton, Ph.D., ABPP, CDCES Center Director of the Nemours Center for Healthcare Delivery Science in Florida, has secured a three-year, $900,000 NIH R01 grant entitled, "Coin2Dose: Behavioral economics to promote insulin bolus activity and improve HbA1c in teens." Dr. Patton is the recipient of three concurrent R01 grants.

Together with her Nemours co-investigator, Larry A. Fox, M.D., and co-investigators Mark A. Clements, M.D. Ph.D. from Children's Mercy-Kansas City and Christopher C. Cushing, Ph.D. from the University of Kansas, Dr. Patton will examine the feasibility and acceptability of a semi-automated behavioral economics incentive (BEI) mobile health intervention called Coin2Dose to improve self-management behaviors in adolescents with Type 1 diabetes, and then conduct a pilot randomized controlled trial to test the preliminary efficacy of the intervention.

Coin2Dose will deliver automated text messages to cue adolescents to bolus for insulin at mealtimes, plus behavioral economics incentives, in the form of money or digital credits for daily mealtime bolus activity. This study is relevant to public health because most adolescents with Type 1 diabetes struggle to achieve optimal diabetes self-management and their target glycated hemoglobin level (HbA1c) -increasing their risk for serious acute and long-term complications. In addition, behavioral economics incentives can be effective in promoting adolescent self-management.

We are very proud of the novel research that Dr. Patton and her talented team are undertaking as this work will have a high impact on advancing the field of pediatric diabetes treatment by providing a scalable adherence-focused intervention for immediate clinic uptake as well as for use in future focused interventions."

Vicky Funanage, Ph.D., Executive Director of Research at Nemours

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Diabetes medication shows promise in reducing alcohol use